Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    29-November-2000      
Issue 230 Next Update - 14:00 UTC 08:00 EST    30-November-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya In Today's Vidyya
Get a focus on organizations that support free access to medical information in today's Vidyya.

Back To Vidyya The Flow Of Global Information - Should Knowledge Be Free?
The electronic revolution that is currently widening the information gap will eventually narrow, and perhaps even abolish, the gap. It will always be expensive and slow to send journals to the developing world. The marginal cost of sending the paper editions of the Lancet or the BMJ every week for a year to Africa is well over 50, and they can take months to arrive. What is more, those in resource poor countries can access electronic journals at exactly the same time as those in the developed world. Read an editorial by individuals that are calling on major publishers to provide information at lower or free cost to the developing world. More...

Back To Vidyya Free Access To Information - The PubMed Central Project
PubMed Central is a barrier-free NIH repository for peer-reviewed primary research reports in the life sciences, which began accepting journal articles in January 2000. More...

Back To Vidyya E-Medicine - Cutting Edge Emergency Medicine Textbook With Real Time Updates
What sets this site apart from other medical information databases is the cutting-edge nature of the information available. The doctors who author the text available on the E-medicine site log-on to the site and update their chapters at any time, day or night. This means that E-medicine delivers the most contemporary medical information in an accessible medium with no cost to users. More...

Back To Vidyya Drug Safety Warning - Xeloda
Roche Laboratories is informing health practitioners of important safety-related changes to the prescribing information concerning the use of Xeloda in patients with renal impairment at baseline. A copy of the complete revised labeling is included in this issue of Vidyya More...

Back To Vidyya

Prescribing Information - Xeloda
Get the full prescribing information for Xeloda, a newer breast cancer therapy that has recently had to change it's labeling to adjust for patients with renal impairment. More...

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.